Article Text

Download PDFPDF

Randomised pilot trial of cash incentives for reducing paediatric asthmatic tobacco smoke exposures from maternal caregivers and members of their social network
  1. Mandeep S Jassal1,
  2. Cassia Lewis-Land1,
  3. Richard E Thompson2,
  4. Arlene Butz1
  1. 1 Department of Pediatrics, Johns Hopkins Medicine, Baltimore, Maryland, USA
  2. 2 Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA
  1. Correspondence to Dr Mandeep S Jassal, Johns Hopkins Medicine, Baltimore, MD 21287-0010, USA; mjassal1{at}jhmi.edu

Abstract

Background The primary aim was to evaluate the efficacy of financial incentives for reducing paediatric tobacco smoke exposures (TSEs) through motivating cigarette usage reduction among low-income maternal caregivers and members of their social network.

Design Randomised control pilot trial over a 6-month study follow-up time period. The study was undertaken from May 2017 to -May 2018. Once monthly follow-up visits occurred over the 6-month study period.

Setting Baltimore City, Maryland, USA.

Participants We grouped 135 participants into 45 triads (asthmatic child (2–12 years of age), maternal caregiver and social network member). Triads were assigned in a 1:1 allocation ratio. The maternal caregiver and social network members were active smokers and contributed to paediatric TSE.

Interventions Triads were randomised to receive either usual care (TSE education and quitline referrals) or usual care plus financial incentives. Cash incentives up to $1000 were earned by caregivers and designated social network participants. Incentives for either caregivers or social network participants were provided contingent on their individual reduction of tobacco usage measured by biomarkers of tobacco usage. Study visits occurred once a month during the 6-month trial.

Main outcome measures The main outcome measure was mean change in monthly paediatric cotinine levels over 6 months of follow-up interval and was analysed on an intention-to-treat basis.

Results The mean change in monthly child cotinine values was not significantly different in the intervention cohort over the 6-month follow-up period, compared with the control group (p=0.098, CI −0.16 to 1.89). Trends in child cotinine could not be ascribed to caregivers or social network members. Despite decreasing mean monthly cotinine values, neither the intervention cohort’s caregivers (difference in slope (control–intervention)=3.30 ng/mL/month, CI −7.72 to 1.13, p=0.144) or paired social network members (difference in slope (control–intervention)=−1.59 ng/mL/month, CI −3.57 to 6.74, p=0.546) had significantly different cotinine levels than counterparts in the control group.

Conclusions Financial incentives directed at adult contributors to paediatric TSE did not decrease child cotinine levels.

Trial registration number NCT03099811.

  • community child health
  • race and health
  • respiratory
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MSJ, CL-L and AB conceptualised and designed the study. MSJ, CL-L, RET and AB were involved in the analysis and interpretation of the data. MSJ drafted the initial manuscript. CL-L, RET and AB revised the manuscript critically for important intellectual content. All authors agreed to be accountable for all aspects of the work and provided approval of the final manuscript version.

  • Funding This work was funded by the National Institute of Environmental Health Sciences (K23ES023814). All phases of this study were supported by the National Institute of Environmental Health Sciences (K23ES023814).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The protocol was approved by the institutional review board at The Johns Hopkins University School of Medicine (IRB00064875).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Linked Articles

  • Atoms
    Nick Brown